Comparative analyses of tumour immune microenvironment between collecting duct carcinoma and fumarate hydratase-deficient renal cell carcinoma.

Daisuke KiyozawaKenichi KohashiDai TakamatsuShinya UmekitaMasatoshi EtoMitsuru KinjoKenichi NishiyamaKenichi TaguchiYumi OshiroYusuke KuboyamaYoshinao Oda

Published in: Journal of clinical pathology (2022)

Our results suggest the difference of each tumour microenvironment between CDC and FH-deficient RCC, and IL-8 is a potential therapeutic target for treating CDC, but not FH-deficient RCC.

Keyphrases

renal cell carcinoma
stem cells
cell cycle
wild type
cell proliferation